v3.10.0.1
CONDENSED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Operating expenses:        
Research and development $ 744,173 $ 1,124,506 $ 3,056,101 $ 3,802,149
General and administrative 2,405,722 786,948 8,492,070 4,020,625
Depreciation 2,977 2,834 8,806 8,900
Total operating expenses 3,152,872 1,914,288 11,556,977 7,831,674
Loss from operations (3,152,872) (1,914,288) (11,556,977) (7,831,674)
Other income (expense):        
Gain (loss) on change in fair value of derivatives 0 113,724 0 (320,131)
Interest income 1,943 15 2,291 69
Loss before income taxes (3,150,929) (1,800,549) (11,554,686) (8,151,736)
Income taxes (benefit) 0 0 0 0
Net loss (3,150,929) (1,800,549) (11,554,686) (8,151,736)
Preferred stock dividend (194,433) (22,307) (780,346) (68,915)
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS $ (3,345,362) $ (1,822,856) $ (12,335,032) $ (8,220,651)
Net loss per common share, basic and diluted (in Dollars per share) $ (0.22) $ (0.17) $ (0.89) $ (0.83)
Weighted average number of common shares outstanding, basic and diluted (in Shares) 15,529,568 10,428,563 13,784,553 9,905,060

Source